Roche Holding AG Participation (ROGN)

5,991.220
-0.370(-0.01%)
  • Volume:
    94
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    5,881.120 - 5,991.220
Trading near 52-week Low

Roche Holding Participation has hit the lowest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

ROGN Historical Data

Time Frame:
Daily
12/13/2022 - 01/29/2023
5,991.2205,881.1205,991.2205,881.1200.09K-0.01%
5,991.2205,881.1205,991.2205,881.1200.09K-0.01%
5,991.5905,991.5905,991.5905,991.5900.07K-0.68%
5,991.5905,991.5905,991.5905,991.5900.07K-0.68%
6,032.4006,134.0806,134.0806,032.4000.21K+0.34%
6,032.4006,134.0806,134.0806,032.4000.21K+0.34%
6,012.0306,012.0306,012.0306,012.0300.05K+1.65%
6,012.0306,012.0306,012.0306,012.0300.05K+1.65%
5,914.1706,137.4506,137.4505,914.1700.02K-4.10%
5,914.1706,137.4506,137.4505,914.1700.02K-4.10%
6,166.8506,166.8506,166.8506,166.8502.46K+2.85%
6,166.8506,166.8506,166.8506,166.8502.46K+2.85%
5,996.1205,996.1205,996.1205,996.1200.30K-0.20%
5,996.1205,996.1205,996.1205,996.1200.30K-0.20%
6,008.3006,008.3006,008.3006,008.3000.43K+0.83%
6,008.3006,008.3006,008.3006,008.3000.43K+0.83%
5,958.9405,958.9405,958.9405,958.9400.32K+0.65%
5,958.9405,958.9405,958.9405,958.9400.32K+0.65%
5,920.6005,920.6005,920.6005,920.6000.01K-1.84%
5,920.6005,920.6005,920.6005,920.6000.01K-1.84%
6,031.6106,031.6106,031.6106,031.6100.27K-5.65%
6,031.6106,031.6106,031.6106,031.6100.27K-5.65%
6,392.6606,392.6606,392.6606,392.6600.01K+2.66%
6,392.6606,392.6606,392.6606,392.6600.01K+2.66%
6,227.1406,227.1406,227.1406,227.1400.03K+1.54%
6,227.1406,227.1406,227.1406,227.1400.03K+1.54%
6,132.7406,269.7906,269.7906,132.7401.04K-1.64%
6,234.8806,234.8806,234.8806,234.8800.72K-2.31%
6,382.2906,240.5206,382.2906,240.5200.14K-2.57%
6,550.6506,543.9106,550.6506,543.9100.08K+9.34%
Highest: 6,550.650Lowest: 5,881.120Difference: 669.530Average: 6,086.261Change %: -2.308
  • When ist best time to buy?
    0
    • SP suffering since May 2022 due to decline in COVID vaccines.
      0
      • macd indicators showing a nice jump coming, keeping my fingers crossed during these dark times
        0
        • What happened today?
          0
          • The SKYSCRAPER-01 study evaluating tiragolumab plus Tecentriq did not meet its co-primary endpoint of progression-free survival
            0
          • Today only this info about Roche
            0
        • A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
          4
          • hello to Marinopoulos Pharma company .!
            0
        • Trades ex dividend!!
          0
          • Currently near to Fibo 61.8 levels, a great company to buy IMO.
            0
            • Any comments?
              0
              • Still holding, not a good stock tho..
                2
            • cant make it even during pandemic, sell
              2
              • I've invested in Roche.VX, is it the right stock?
                0